Nur-Isterate 200 mg/mL Solution for injection
PDF Leaflet Revision Date: 14 April 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Hormonal contraception.
Dosage (summary)
200 mg IM within first 5 days of cycle; subsequent injections every 8 weeks, then every 12 weeks.
Special Populations
- Breastfeeding women
- Diabetics
Pregnancy & Breastfeeding
Contraindicated in pregnancy; minimal transfer to breast milk.
Key Drug Interactions
- Enzyme inducers (e.g., rifampicin)
- CYP3A4 inhibitors (e.g., azole antifungals)
Contraindications
- Hypersensitivity
- Pregnancy
- Venous thromboembolic disorders
- Arterial disease
- Uncontrolled hypertension
Common side effects
- Cycle disturbances
- Dizziness
- Nausea
- Depressed mood
Counselling Points
- Use barrier method for first 7 days after switching
- Report any mood changes
- Not effective against STIs
Serious warnings
- Increased risk of thromboembolic events
- Monitor for signs of depression
Important Disclaimer
The Nur-Isterate 200 mg/mL Solution for injection professional information leaflet below is the property of Bayer and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
